U.S. Hemoglobinopathies (Thalassemia, Sickle Cell Disease) Market Analysis Report 2024-2030: Ongoing Research into Novel Treatment Options & CRISPR-Cas9 Holds Promise for More Effective Therapies Dublin, July 29, 2024 (GLOBE NEWSWIRE) -- The "U.S. Hemoglobinopathies Market Size, Share & Trends Analysis Report by Type (Thalassemia, Sickle Cell Disease), Diagnosis (Thalassemia, Sickle Cell...

Rising Prevalence of Hemoglobin Disorders Drives Hemoglobinopathies Market Growth: $12.21 Million Market by 2027 Dublin, July 31, 2023 (GLOBE NEWSWIRE) -- The "Hemoglobinopathies Competitive Landscape and Market Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global...

North America Hemoglobinopathies Market Analysis Report 2022: Focus on Thalassemia and Sickle Cell Disease - Forecasts to 2028 Dublin, March 07, 2023 (GLOBE NEWSWIRE) -- The "North America Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution...

Global Hemoglobinopathies Market Report 2022: Featuring Abbott, Sanofi, Danaher, Pfizer, Merck & More Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel,...

The Worldwide Hemoglobinopathies Industry is Expected to Reach $7 Billion by 2031 Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Hemoglobinopathies Market By Type, By Therapy, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...